Related Experiment Video

Updated: May 11, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Insulin resistance: an emerging link in Alzheimer's disease

Bikash Medhi1, Mrinmoy Chakrabarty

  • 1Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Research Block B, 4th Floor, Room No. 4043, Chandigarh, 160012, India, drbikashus@yahoo.com.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|May 15, 2013
PubMed

Insights

Alzheimer's disease (AD) progression may stem from brain insulin resistance, leading to neuronal damage and iron overload. Targeting neuronal glycemic imbalance offers a new therapeutic avenue for AD.

Area of Science:

  • Neuroscience
  • Biomedical Research
  • Metabolic Disorders

Background:

  • Alzheimer's disease (AD) presents a significant challenge, with many clinical trials failing.
  • Emerging research highlights neuronal glycemic imbalance and brain insulin resistance as key factors in AD pathogenesis.
  • Insulin's role in neuronal iron distribution is critical; resistance leads to detrimental iron overload.

Purpose of the Study:

  • To explore the link between brain insulin resistance and Alzheimer's disease.
  • To investigate the role of neuronal glycemic imbalance in AD development.
  • To examine the connection between insulin resistance, iron metabolism, and neurodegeneration in AD.

Main Methods:

  • Review of recent scientific literature on Alzheimer's disease and insulin resistance.
  • Analysis of studies investigating neuronal glycemic control and its impact on AD pathology.
  • Examination of research on iron metabolism dysregulation in the context of brain insulin resistance.

Main Results:

  • Brain insulin resistance contributes to amyloid plaque and tau hyperphosphorylation.
  • Insulin resistance disrupts iron distribution, causing toxic iron accumulation in neurons.
  • C-Jun-N-terminal kinase 3 (JNK3) emerges as a potential mediator linking insulin resistance and AD.

Conclusions:

  • Neuronal insulin resistance is a critical factor in Alzheimer's disease progression.
  • Targeting brain insulin resistance and associated iron dysregulation may offer novel therapeutic strategies for AD.
  • Further research into the JNK3 pathway's role in insulin-resistant neurodegeneration is warranted.

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay08:34

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...